MedKoo Cat#: 527981 | Name: Chlortoluron-mecoprop mixt.

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Chlortoluron-mecoprop mixt. is a bioactive chemical mixture.

Chemical Structure

Chlortoluron-mecoprop mixt.
Chlortoluron-mecoprop mixt.
CAS#37341-10-9

Theoretical Analysis

MedKoo Cat#: 527981

Name: Chlortoluron-mecoprop mixt.

CAS#: 37341-10-9

Chemical Formula: C20H24Cl2N2O4

Exact Mass: 426.1113

Molecular Weight: 427.32

Elemental Analysis: C, 56.22; H, 5.66; Cl, 16.59; N, 6.56; O, 14.98

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Chlortoluron-mecoprop mixt.
IUPAC/Chemical Name
Propanoic acid, 2-(4-chloro-2-methylphenoxy)-, mixt. with N-(3-chloro-4-methylphenyl)-N,N-dimethylurea
InChi Key
ROGAZCSFJFDQIC-UHFFFAOYSA-N
InChi Code
InChI=1S/C10H13ClN2O.C10H11ClO3/c1-7-4-5-8(6-9(7)11)12-10(14)13(2)3;1-6-5-8(11)3-4-9(6)14-7(2)10(12)13/h4-6H,1-3H3,(H,12,14);3-5,7H,1-2H3,(H,12,13)
SMILES Code
CC(OC1=CC=C(Cl)C=C1C)C(O)=O.O=C(NC2=CC=C(C)C(Cl)=C2)N(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 427.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Tsvetkova OA, Kolosova KY. [Exacerbation of chronic obstructive pulmonary disease: the role of the molecular genetic method for the identification of pathogenic agents]. Klin Med (Mosk). 2016;94(10):770-4. Russian. PubMed PMID: 30299032. 2: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501887/ PubMed PMID: 30000947. 3: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501799/ PubMed PMID: 30000858. 4: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501738/ PubMed PMID: 30000797. 5: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501707/ PubMed PMID: 30000767. 6: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501691/ PubMed PMID: 30000751. 7: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501478/ PubMed PMID: 30000538. 8: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501328/ PubMed PMID: 30000387. 9: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501289/ PubMed PMID: 30000348. 10: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501113/ PubMed PMID: 30000172. 11: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501068/ PubMed PMID: 30000127. 12: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500987/ PubMed PMID: 30000046. 13: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500983/ PubMed PMID: 30000042. 14: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500776/ PubMed PMID: 29999835. 15: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500760/ PubMed PMID: 29999819. 16: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500750/ PubMed PMID: 29999809. 17: Dumeaux V, Fjukstad B, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Børresen-Dale AL, Bongo LA, Lund E, Hallett M. Interactions between the tumor and the blood systemic response of breast cancer patients. PLoS Comput Biol. 2017 Sep 28;13(9):e1005680. doi: 10.1371/journal.pcbi.1005680. eCollection 2017 Sep. PubMed PMID: 28957325; PubMed Central PMCID: PMC5619688. 18: Irimie A, Piciu D. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology. Curr Radiopharm. 2017 Nov 10;10(3):146-154. doi: 10.2174/1874471010666170816125402. Review. PubMed PMID: 28814251. 19: Seco-Cervera M, González-Rodríguez D, Ibáñez-Cabellos JS, Peiró-Chova L, González-Cabo P, García-López E, Vílchez JJ, Sanz-Gallego I, Pallardó FV, García-Giménez JL. Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich's ataxia patients. Sci Rep. 2017 Jul 12;7(1):5237. doi: 10.1038/s41598-017-04996-9. PubMed PMID: 28701783; PubMed Central PMCID: PMC5507909. 20: Seror O, Sutter O. RE: Should We Use a Monopolar or Bipolar Mode for Performing No-Touch Radiofrequency Ablation of Liver Tumors? Clinical Practice Might have Already Resolved the Matter Once and for All. Korean J Radiol. 2017 Jul-Aug;18(4):749-752. doi: 10.3348/kjr.2017.18.4.749. Epub 2017 May 19. PubMed PMID: 28670170; PubMed Central PMCID: PMC5447651.